ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRW Craneware Plc

2,220.00
-20.00 (-0.89%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Craneware Plc LSE:CRW London Ordinary Share GB00B2425G68 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -0.89% 2,220.00 2,180.00 2,250.00 2,230.00 2,190.00 2,190.00 560,547 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Prepackaged Software 174.02M 9.23M 0.2626 84.35 778.74M

Craneware plc Grant of Long Term Incentive Plan Awards (0860H)

21/11/2022 11:40am

UK Regulatory


Craneware (LSE:CRW)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Craneware Charts.

TIDMCRW

RNS Number : 0860H

Craneware plc

21 November 2022

Craneware plc

("Craneware" or the "Company")

Grant of Long Term Incentive Plan Awards

21 November 2022 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 18 November 2022 , under the terms of the Craneware plc Long Term Incentive Plan (2022) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") was granted to three Directors of the Company as follows:

 
        Director             No. of Shares over      Percentage of issued 
                             which a conditional         share capital 
                           share award was granted 
 Keith Neilson (CEO)               30,796                   0.09% 
                         -------------------------  --------------------- 
 Craig Preston (CFO)               22,890                   0.06% 
                         -------------------------  --------------------- 
 Isabel Urquhart (CPO)             15,734                   0.04% 
                         -------------------------  --------------------- 
 

The awards will ordinarily vest after three years subject to:

(i) the satisfaction of certain performance conditions (each with 50% weighting) based on: (a) the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index; and (b) compound annual growth in adjusted diluted earnings per share, as reported in the consolidated financial statements of the Company and its subsidiaries; and

(ii) the Director's continued employment.

The performance conditions are measured in three tranches such that one third of the Shares over which the LTIP awards subsist will vest based on performance over the three years ending on 30 June 2023, one third based on performance over the three years ending 30 June 2024 and the final third based on performance over the three years to 30 June 2025 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse.

If and to the extent that these LTIP awards vest, the resulting (net of tax) Shares will be subject to a two year holding period.

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest.

PDMR notification: Keith Neilson

   1.   Details of the Restricted Person / person closely associated with him or her 
   a) Name                                                            Keith Neilson 
   2.   Reason for the notification 
   a) Position / status                                            CEO 
   b) Initial notification / Amendment                     Initial notification 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

   a) Name                                                            Craneware plc 
   b) LEI                                                                213800O2CTJ1YFXNXG05 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

   b) Identification code                                         ISIN GB00B2425G68 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2022)

d) Price(s) and volume(s) Volume(s) granted 30,796 , Price(s) GBP0

e) Aggregated information:

                                       i. Aggregated volume       Aggregate volume granted 30,796 
                                       ii. Price                                     Price(s) GBP0 
   f) Date of the transaction                                  2022-11-18 
   g) Place of the transaction                                 Outside a trading venue 

PDMR notification: Craig Preston

   1.   Details of the Restricted Person / person closely associated with him or her 
   a) Name                                                            Craig Preston 
   2.   Reason for the notification 
   a) Position / status                                            CFO 
   b) Initial notification / Amendment                     Initial notification 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

   a) Name                                                            Craneware plc 
   b) LEI                                                                213800O2CTJ1YFXNXG05 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

   b) Identification code                                         ISIN GB00B2425G68 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2022)

d) Price(s) and volume(s) Volume(s) granted 22,890 , Price(s) GBP0

e) Aggregated information:

                                       i. Aggregated volume       Aggregate volume granted 22,890 
                                       ii. Price                             Price(s) GBP0 
   f) Date of the transaction                                   2022-11-18 
   g) Place of the transaction                                 Outside a trading venue 

PDMR notification: Isabel Urquhart

   1.   Details of the Restricted Person / person closely associated with him or her 
   a) Name                                                            Isabel Urquhart 
   2.   Reason for the notification 
   a) Position / status                                            Chief People Officer 
   b) Initial notification / Amendment                       Initial notification 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

   a) Name                                                            Craneware plc 
   b) LEI                                                                213800O2CTJ1YFXNXG05 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

   b) Identification code                                         ISIN GB00B2425G68 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2022)

d) Price(s) and volume(s) Volume(s) granted 15,734 , Price(s) GBP0

e) Aggregated information:

                                       i. Aggregated volume                Aggregate volume granted 15,734 
                                       ii. Price                                     Price(s) GBP0 
   f) Date of the transaction                                  2022-11-18 
   g) Place of the transaction                                 Outside a trading venue 

For further information, please contact:

 
 Craneware plc                                                 +44 (0)131 550 3100 
 Keith Neilson, CEO 
 Craig Preston, CFO 
 
 Alma (Financial PR)                                           +44 (0)20 3405 0205 
 Caroline Forde, Hilary Buchanan, Joe Pederzolli               craneware@almapr.co.uk 
 
 Peel Hunt (NOMAD and Joint Broker)                            +44 (0)20 7418 8900 
 Dan Webster, Andrew Clark 
 
 Investec Bank PLC (Joint Broker)                              +44 (0)20 7597 5970 
 Patrick Robb, Henry Reast, Sebastian Lawrence 
 
 Berenberg (Joint Broker)                                      +44 (0)20 3207 7800 
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff 
 

About Craneware

We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence- something no other single partner can provide.

Together, approximately 40% of registered US hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFEIFFFEESEDF

(END) Dow Jones Newswires

November 21, 2022 06:40 ET (11:40 GMT)

1 Year Craneware Chart

1 Year Craneware Chart

1 Month Craneware Chart

1 Month Craneware Chart

Your Recent History

Delayed Upgrade Clock